Literature DB >> 6147717

Intraprostatic concentrations of ciprofloxacin after intravenous administration.

J B Boerema, F M Debruyne, A Dalhoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6147717     DOI： 10.1016/s0140-6736(84)91252-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  A new method for assaying antimicrobials in the prostate.

Authors:  A C Philpott; E D Crawford; G J Miller
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Single and multiple dose pharmacokinetics of ciprofloxacin.

Authors:  U Ullmann; W Giebel; A Dalhoff; P Koeppe
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

3.  Ciprofloxacin concentrations in tonsils following single or multiple administrations.

Authors:  N Falser; A Dalhoff; H Weuta
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 4.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 5.  Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

6.  Ciprofloxacin pharmacokinetics in patients with cystic fibrosis.

Authors:  S W Bender; A Dalhoff; P M Shah; R Strehl; H G Posselt
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

7.  New 4-quinolones in the treatment of urinary tract infections.

Authors:  J B Boerema
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

8.  Tissue distribution of ciprofloxacin following oral and intravenous administration.

Authors:  A Dalhoff; H U Eickenberg
Journal:  Infection       Date:  1985 Mar-Apr       Impact factor: 3.553
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.